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The Golgi apparatus is an essential cellular organelle for post-translational modifications,
sorting, and trafficking of membrane and secretory proteins. Proper functionality of
the Golgi requires the formation of its unique cisternal-stacking morphology. The Golgi
structure is disrupted in a variety of neurodegenerative diseases, suggesting a common
mechanism and contribution of Golgi defects in neurodegenerative disorders. A recent
study on Alzheimer’s disease (AD) revealed that phosphorylation of the Golgi stacking
protein GRASP65 disrupts its function in Golgi structure formation, resulting in Golgi
fragmentation. Inhibiting GRASP65 phosphorylation restores the Golgi morphology from
Aβ-induced fragmentation and reduces Aβ production. Perturbing Golgi structure and
function in neurons may directly impact trafficking, processing, and sorting of a variety
of proteins essential for synaptic and dendritic integrity. Therefore, Golgi defects may
ultimately promote the development of AD. In the current review, we focus on the
cellular impact of impaired Golgi morphology and its potential relationship to AD disease
development.
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Introduction
The Golgi apparatus is a membranous cellular organelle that mediates proper trafficking, post-
translational processing, and sorting of membrane and secretory proteins. The Golgi is often
localized to the perinuclear region of the cell, which depends on an intact microtubule network
and a motor protein dynein. Golgi membranes form multilayer stacks that are laterally linked
into a ribbon. Formation of stable multilayer stacks and ribbons appears to be essential for proper
functioning of the Golgi (Rambourg et al., 1987; Ladinsky et al., 1999; Klumperman, 2011; Klute
et al., 2011). The Golgi structure is controlled by Golgi matrix proteins, a group of peripheral
and membrane proteins localized on the cytoplasmic surface of Golgi membranes, including the
coiled-coil domain-containing golgins and the stacking proteins GRASP55/65 (Ramirez and Lowe,
2009; Xiang and Wang, 2011; Wong and Munro, 2014). Depletion of Golgi matrix proteins such
as GRASP65 (Xiang et al., 2013; Veenendaal et al., 2014), GRASP55 (Feinstein and Linstedt,
2008; Xiang and Wang, 2010), GM130 (Puthenveedu et al., 2006), golgin-84 (Diao et al., 2003),
and golgin-160 (Williams et al., 2006), or treatment of cells with pharmacological drugs such as
Brefeldin A (BFA) (Klausner et al., 1992), results in an abnormal, fragmented Golgi morphology.
Disruption of normal Golgi morphology directly impacts protein trafficking and processing. For
example, breaking down the Golgi ribbon of mammalian cells by nocodazole treatment strongly
inhibits intra-Golgi transport of large cargoes without altering the rate of transport of smaller
cargoes (Lavieu et al., 2014), while inhibition of stack formation by knocking down GRASP55/65
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by RNA interference (RNAi) accelerates protein trafficking,
impairs proper glycosylation, and leads to missorting and
delivery of lysosomal proteins to the extracellular space (Xiang
et al., 2013). Thus, the structure of the Golgi is closely linked to
vital cellular processes.
Golgi fragmentation has been observed in neurodegenerative
diseases, including Alzheimer’s (AD) (Stieber et al., 1996; Huse
et al., 2002), Parkinson’s (PD) (Mizuno et al., 2001), and
Huntington’s (HD) (Hilditch-Maguire et al., 2000) diseases and
amyotrophic lateral sclerosis (ALS) (Mourelatos et al., 1996;
Gonatas et al., 1998; Fujita and Okamoto, 2005). However,
the molecular basis of Golgi fragmentation and its role in
disease progression remain largely unexplored. Golgi defects
may impact the trafficking and processing of many proteins
essential for neuronal functions. Thus, morphological and
subsequent functional impairments of the Golgi may contribute
to the neurotoxicity associated with neurodegenerative diseases.
Understanding the mechanisms that cause Golgi fragmentation
and its downstream effects on neuronal functions are likely
important for understanding the molecular basis of the diseases.
Furthermore, targeting Golgi structural defects may represent a
novel approach to treating or preventing related diseases with
Golgi defects. In this review, we summarize the current literature
on the cause and effect of Golgi fragmentation in AD, the leading
cause of dementia in adults (Alzheimer’s, 2015).
Golgi and Amyloid Plaque Formation
One neuropathological hallmark of AD is the formation of
extracellular amyloid plaques by secreted amyloid beta (Aβ)
peptides (Nelson et al., 2009), which is highly related to Golgi
structure and function (Figure 1). Aβ is derived from the
amyloid precursor protein (APP), a type I membrane protein
that travels through the exocytic and endocytic pathways and
undergoes sequential proteolysis by the action of β- and γ-
secretases (Vassar et al., 1999). In neurons, APP is transported
from the Golgi to many sub-cellular compartments (Haass et al.,
1992), including the soma, dendrites and axons, through the
exocytic and endocytic pathways. Despite the abundant literature
demonstrating the critical role of endosomes in APP processing
(for review see Suh and Checler, 2002; Small and Gandy, 2006),
it has been indicated that the Golgi (in particular the trans-
Golgi network) may be a site where Aβ is generated in the
cell (Greenfield et al., 1999; Burgos et al., 2010; Choy et al.,
2012). In addition, proper functioning of the Golgi is required
for trafficking and maturation of both APP and its processing
enzymes. For instance, the activity of the γ-secretase depends
on the trafficking and maturation of nicastrin (Chung and
Struhl, 2001) and other components of the γ-secretase complex
through the Golgi (Herreman et al., 2003). Nicastrin is not
catalytically active, but is important for the maturation and
proper trafficking of the γ-secretase complex (Zhang et al., 2005).
Nicastrin functions to stabilize presenilins (PSs), the catalytic
subunit of the γ-secretase complex, andmediates PS trafficking to
the cell surface by an unknown mechanism (Edbauer et al., 2002;
Hu et al., 2002). Nicastrin also binds to the N-terminal domain
of APP, and facilitates APP trafficking and cleavage (Yu et al.,
2000; Kimberly et al., 2002). APP travels from the endoplasmic
reticulum (ER) through the Golgi to the plasma membrane. The
majority of APP localizes to the Golgi where it undergoes post-
translational modifications and only a small fraction resides in
the ER and the plasma membrane (Thinakaran and Koo, 2008).
Finally, the α-secretatse ADAM10 is transported from dendritic
Golgi outposts to synaptic membranes, a reaction modulated
by the synapse-associated protein-97 (SAP97) (Saraceno et al.,
2014). Thus, APP processing and Aβ production are intrinsically
linked to the proper morphology and functionality of the Golgi.
Golgi and Tau Pathology in AD
Another pathological distinction in AD is the formation
of neurofibrillary tangles (NFTs) caused by precipitation of
hyperphosphorylated tau protein, which is also related to Golgi
structure and function (Figure 1) (Morishima-Kawashima and
Ihara, 2002). Tau is an abundant protein that binds and stabilizes
microtubules in neurons (Gong andAlonso Adel, 2013). Neurons
have long protrusions such as axons; transport of membrane
organelles and proteins into and from these protrusions highly
depends on an intact microtubule network (Baas, 2002). Long
microtubules emanate out of the centrosomes and function as the
track for rapid transport of membranes by kinesin and dynein
motors (Hancock, 2014). Membranes and proteins for synaptic
vesicle formation and synaptic function are essentially all
transported in this way (Gallant, 2000; Goldstein and Yang, 2000).
In AD, hyperphosphorylation of tau results in NFT formation,
which impairs microtubule integrity and blocks membrane
transport (Patrick et al., 1999; Avila, 2006; Baloyannis, 2014).
Interestingly, the Golgi, whose formation relies on an intact
microtubule network (Rios and Bornens, 2003), may also
function as an important microtubule organization center
(Lewis and Polleux, 2012; Ori-McKenney et al., 2012; Zhu
and Kaverina, 2013). Multiple microtubule-binding proteins,
such as γ-tubulin (Radulescu et al., 2011), CLASP (Liu et al.,
2007; Miller et al., 2009), GMAP-210 (Infante et al., 1999;
Roboti et al., 2015), and GM130 (Rivero et al., 2009), are
localized on the Golgi membranes and modulate microtubule
network formation and membrane trafficking in neurons (Rios,
2014; Tang et al., 2015) and astrocytes (Yoshiyama et al.,
2003). It has been reported that tau interacts with Golgi
membranes and mediates their association with microtubules
(Farah et al., 2006). Overexpression of wild-type and mutant
human tau proteins causes Golgi fragmentation in primary
hippocampal neurons (Liazoghli et al., 2005), implying that
overabundance of tau, and potentially NFT formation, precedes
Golgi morphological defects. Additionally, Golgi fragmentation
may affect tau phosphorylation (Jiang et al., 2014) and promote
NFTs formation in AD (Grundke-Iqbal et al., 1986). Therefore,
there is a close connection between Golgi morphology and
function, microtubule organization, and tau pathology in AD.
Golgi Morphological Defects in AD
Golgi morphological alterations have been observed in neurons
of AD patients (Dal Canto, 1996; Stieber et al., 1996; Gonatas
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FIGURE 1 | Golgi Morphological and Functional Defects in AD. (A) Under normal conditions, the structure of the Golgi is maintained by active Golgi structural
proteins such as GRASP65 (non-phosphorylated) and an intact microtubule (MT) network. Maintaining the Golgi structure is essential for proper trafficking and
processing of APP and its processing enzymes. The majority of APP undergoes non-amyloidogenic processing, and cell-surface proteins, lipids, and polysaccharides,
which are essential for neuronal function, are properly sorted and transported. Together, these factors maintain neuronal functionality and viability. (B) In AD, the Golgi is
fragmented due to inactivation of Golgi structural proteins, such as degradation or phosphorylation of GRASP65 (pGRASP65), or tau hyper phosphorylation (pTau) and
NFT formation that disrupt MT dynamics and protein trafficking. Golgi fragmentation impairs trafficking, processing, and sorting of APP and APP-processing enzymes,
which stimulates amyloidogenic APP cleavage and further inactivates GRASP65. Additionally, Golgi fragmentation is predicted to alter trafficking, processing, and
sorting of proteins, lipids, and polysaccharides that are essential for neuronal function; which could ultimately promote neuronal dysfunction and/or cell death.
et al., 1998; Huse et al., 2002), which occur even before the
formation of NFTs and neuritic plaques (Baloyannis, 2014).
Golgi fragmentation has been recently confirmed in AD tissue
culture and mouse models (Joshi et al., 2014). Expression of
the Swedish mutant APP (APPswe) and the exon 9-deletion
mutant PS1 (PS11E9) in cells and mouse brain, or treatment
of neurons with synthetic Aβ peptides, resulted in Golgi
fragmentation. Under fluorescence microscopy, Golgi elements
are unlinked and dispersed into the cytoplasm. Under electron
microscopy (EM), the disconnected Golgi stacks exhibit reduced
number of cisternae per stack, shorter cisternae, more vesicles
surrounding each stack and a dilated Golgi structure compared
with wild type cells and untreated neurons (Joshi et al., 2014).
In this study, the direct cause of Golgi fragmentation is Aβ
accumulation, as Aβ treatment causes Golgi fragmentation in
cultured neurons and other cell types; this effect is reversible
upon removal of Aβ from the tissue culture medium (Joshi
et al., 2014). Golgi fragmentation has also been observed under
physiological conditions, such as during migration, upon growth
factor treatment, and in neurons with increased neuronal activity
(Bisel et al., 2008; Thayer et al., 2013), suggesting that Golgi
fragmentation may not be an immediate pathological response,
but rather a compensatory reaction to allow fast transport of
proteins to their final destinations when the cells are under stress.
Golgi fragmentation, however, impacts protein glycosylation and
sorting (Wang et al., 2008; Xiang et al., 2013), as we discuss below.
Mechanisms of Golgi Morphological
Defects in AD
The formation and maintenance of the perinuclear localization
of the Golgi ribbon rely on an intact microtubule cytoskeleton
emanating from the perinuclear centrosomes (Glick and Nakano,
2009; Yadav and Linstedt, 2011; Rios, 2014). The minus end-
directed motor dynein associates with the Golgi and moves the
membranes along the microtubules toward the centrosomes,
leading to the concentration of the Golgi stacks in the
pericentriolar region and formation of the Golgi ribbon (Rios
and Bornens, 2003; Miller et al., 2009). The basic structural and
functional unit of the Golgi is a stack of flattened cisternae.
The exact mechanism for Golgi stack formation is not fully
understood, but is believed to rely on Golgi structural proteins
(Wang and Seemann, 2011; Xiang and Wang, 2011). Among the
well characterized Golgi structural proteins, GRASP65 (Wang
et al., 2003) and GRASP55 (Xiang and Wang, 2010) play
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essential roles in Golgi structure formation, whereas others,
including GM130 (Lowe et al., 1998), golgin-160 (Hicks and
Machamer, 2002), and p115 (Chiu et al., 2002), are more
important for trafficking across the Golgi stack (Xiang and
Wang, 2011). For example, GRASP65 forms oligomers that tether
the cisternae into stacks (Wang et al., 2003; Tang et al., 2010;
Lavieu et al., 2013) and ribbons (Puthenveedu et al., 2006).
Recently a GRASP65 knockout mouse has been reported, with
defects in cis-Golgi ribbon-linking and no apparent neurological
phenotype (Veenendaal et al., 2014). One potential concern
regarding this mouse strain is that some mRNA encoding exon
1–3 is still present (∼20% of the mRNA level in wild-type mice).
This truncated mRNA encodes a 115 aa N-terminal fragment
of GRASP65. If translated (although not detected by available
antibodies raised against the full length protein), this fragment
would be sufficient for Golgi stacking, according to biochemical
and structural studies (Tang et al., 2010; Truschel et al., 2011).
However, a more recent structure (Feng et al., 2013) indicates
that a longer fragment is needed for GRASP65 function in Golgi
stack formation (Wang et al., 2003, 2005). The lack of a more
prominent Golgi stacking and neurological phenotype may also
be due to the complementation by GRASP55, the homolog of
GRASP65 that shares some redundancy in stacking (Shorter et al.,
1999; Lee et al., 2014).
The mechanism of Golgi fragmentation in AD has not
been well studied, but likely involves multiple mechanisms
(Figure 1). One possibility is through the disruption of the
microtubule network by tau precipitation and NFT formation
(Liazoghli et al., 2005). Microtubule defects may affect both
the central localization of the Golgi in the cell and ER-Golgi-
plasma membrane trafficking that indirectly impacts the size and
morphology of the Golgi (Fokin et al., 2014). Tau could also affect
vesicle trafficking by inhibiting the binding of motor proteins
such as kinesins to microtubules (Seitz et al., 2002). Another
possibility is through modulation of Golgi structural proteins
(Figure 2). Both mitotic phosphorylation and apoptotic cleavage
of Golgi proteins results in Golgi fragmentation (Wang and
Seemann, 2011). For instance, GRASP65 is phosphorylated by
mitotic kinases Cdk1 and Polo-like kinase (Plk1) during mitosis
(Wang et al., 2003) and cleaved by caspase-3 in apoptosis (Lane
et al., 2002), both of which cause Golgi fragmentation (Tang et al.,
2008; Wang and Seemann, 2011). In tissue culture and mouse
models of AD, GRASP65 phosphorylation was implicated as a
major cause of Golgi fragmentation (Joshi et al., 2014; Joshi and
Wang, 2015). At the molecular level, Aβ accumulation triggers
Ca2+ influx (Zempel et al., 2010), which activates Calpain, a
protease known to increase the cleavage of p35 to p25 (Lee et al.,
2000), p25 then activates Cdk5. It has been previously reported
that p35 and Cdk5 are associated with Golgi membranes and
regulate membrane traffic (Paglini et al., 2001). Subsequently,
Cdk5 (also known to phosphorylate tau in AD) phosphorylates
GRASP65, which negatively regulates GRASP65, leading to Golgi
fragmentation. Consequently, Golgi fragmentation enhances
APP trafficking and increases Aβ production (Joshi et al.,
2014). Fragmentation of the Golgi was rapidly reversible by
the use of Cdk5-specific inhibitors, or by expression of non-
phosphorylatable GRASP proteins, both of which significantly
reduced APP trafficking and Aβ production (Figure 2). In the
same study, degradation of Golgi structural proteins was not
detected (Joshi et al., 2014). These results suggest that Golgi
fragmentation in AD, at least in the early stage, is caused
by phosphorylation of Golgi structural proteins, an event that
occurs in parallel with tau hyper-phosphorylation during the
development of the disease. Overall, the causes of Golgi structural
defects in AD are expected to be manifold and require further
investigation to determine the precise mechanisms.
Functional Consequences of Golgi
Fragmentation in AD
Proper Golgi structure formation controls the sequence and
speed of protein transport through the Golgi membranes for
proper trafficking, maturation, sorting, and processing of not
only APP, but also many neuronal proteins (Dries and Yu,
2008; Joshi and Wang, 2015). When BACE1 activity is increased
or Aβ clearance is decreased, Aβ accumulation induces Golgi
fragmentation through modification of GRASP65, and other
Golgi structural proteins (Joshi et al., 2014; Joshi and Wang,
2015). Fragmentation of the Golgi, as one possible outcome,
enhances vesicle budding from the Golgi membranes, accelerates
protein trafficking, and impairs accurate glycosylation (Wang
et al., 2008; Xiang et al., 2013), and thus increases Aβ production
by enhancing amyloidogenic cleavage (Figure 2). APP and
the β-secretase BACE1 are sorted by the Golgi into different
compartments and the loss of the sorting function of the Golgi
by fragmentation in AD results in defective trafficking of APP
and BACE1, which promotes Aβ production (Tan and Evin,
2012; Das et al., 2013; Joshi et al., 2014). This deleterious
feedback loop may impair the integrity of the secretory pathway
for sorting, trafficking and modifications of many essential
neuronal proteins. For example, many AD-related proteins that
are essential for neuronal function, such as NMDA and AMPA
receptors (Pérez-Otaño and Ehlers, 2005; Greger and Esteban,
2007; Shepherd and Huganir, 2007), and synaptic integrity
proteins such as neurexins (Fairless et al., 2008; Reissner et al.,
2013), are processed and trafficked through the Golgi. Thus,
Golgi fragmentation might impair trafficking of membrane
receptors and ion channels that regulate neuronal function
and/or viability (Figure 1).
Long term Golgi defects might also result in a significant
change in the composition of proteins, lipids, and
polysaccharides at the cell surface (Figure 1). A change in
the composition of cell-surface molecules could not only
directly impair neuronal activity and synaptic integrity, but
also potentially trigger an immune response against neurons
with Golgi defects that leads to cell death. In addition, Golgi
defects may impact microtubule organization, tau function, and
cell polarity. The Golgi also functions as a storage reservoir
for Ca2+ (Pinton et al., 1998; Griesbeck et al., 2001), a small
molecule essential for neurotransmission. Ca2+ is a key
regulator of membrane fusion (Pang and Sudhof, 2010), synaptic
plasticity (Neher and Sakaba, 2008), and neurite growth (Tojima
et al., 2011). Defects in calcium signaling has been observed
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FIGURE 2 | Mechanism of Golgi defects in AD. Increased BACE1 activity and/or decreased Aβ clearance from the extracellular space leads to the accumulation of
Aβ. In turn, Aβ induces Ca2+ influx, which activates Calpain and induces cleavage of p35 to p25. Consequently, p25 activates CDK5, which in turn phosphorylates
and inactivates the Golgi structural protein GRASP65 (i.e., pGRASP65). Inactivation of GRASP65 causes Golgi fragmentation, which alters trafficking of APP, and
potentially the secretases, leading to increased Aβ production. This deleterious feedback loop (indicated by black arrows) would impair the integrity of the secretory
pathway for sorting, trafficking and modifications of many essential proteins, which may compromise neuronal function, activate inflammatory responses, or cause
neuronal cell death. Inhibition of CDK5 or expression of non-phosphorylatable GRASP65 mutants restores the normal Golgi morphology and reduces APP trafficking
and Aβ production (indicated by green arrows). Therefore, rescue of the defective Golgi may delay AD development.
in neurodegeneration (Wojda et al., 2008), and prolonged
neuronal hyperexcitability and neuronal activity lead to Golgi
fragmentation (Thayer et al., 2013). Taken together, Golgi defects
may compromise neuron activity and survival through multiple
pathways and serve as an important mechanism of pathogenesis
in AD and other neurodegenerative diseases.
Conclusion
The Golgi apparatus plays an essential role in trafficking and
sorting of proteins that are vital for neuronal functions. The Golgi
is fragmented in many neurodegenerative diseases, suggesting
that Golgi defects may contribute to neurodegeneration.
Golgi fragmentation likely involves multiple mechanisms. In
a recent study on AD, Golgi fragmentation is caused by
phosphorylation of the Golgi structural protein GRASP65 and
Golgi fragmentation results in enhanced APP trafficking and
Aβ production. Golgi fragmentation is predicted to impair
intracellular trafficking of many proteins that are essential for
neuronal function. Restoring Golgi morphological defects might
be an attractive approach to treating, or even preventing, AD.
Understanding the impact of Golgi pathology and determining
the molecular mechanisms that cause Golgi fragmentation is
expected to shed insight into novel therapeutic approaches for
treating AD and potentially other neurodegenerative disorders.
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